The use of fillers and botulinum toxin type A in combination with superficial glycolic acid (alpha-hydroxy acid) peels: optimizing injection therapy with the skin-smoothing properties of peels.
There are many procedures that a physician may utilize to improve the appearance and quality of the skin. Combining procedures can enhance the overall result and lead to increased patient satisfaction. Thus, it is important to choose procedures that will complement each other. Fillers or botulinum toxin type A (BTX-A) can plump the skin and smooth lines and wrinkles but will do little for uneven tone, skin laxity, or radiance and clarity. These signs of aging can be addressed with superficial glycolic acid peels. Methods of combining injectable compounds with superficial glycolic acid peels were discussed at a dermatologist roundtable event and are summarized in this article.
Rendon
Marta I
MI
The NeoStrata Company, Inc, Princeton, New Jersey, USA.
Effron
Cheryl
C
Edison
Brenda L
BL
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002615:Chemexfoliation; D003131:Combined Modality Therapy; D003869:Dermabrasion; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D007271:Injections, Intradermal; D007641:Keratolytic Agents / Q000627:therapeutic use*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D015595:Skin Aging / Q000187:drug effects; D012871:Skin Diseases / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
D006016:Glycolates; D007641:Keratolytic Agents; D009465:Neuromuscular Agents; C031149:glycolic acid; D019274:Botulinum Toxins, Type A